Florida Cancer Specialists & Research Institute Physician Leaders Co-Author National Commentary Examining Patient-Centered 340B Reform

Summary

Florida Cancer Specialists & Research Institute physician leaders published a national commentary in Evidence-Based Oncology examining 340B drug pricing program reform with a framework for greater transparency and accountability in cancer care.